Related Experiment Video
Updated: Jun 16, 2026

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
Infectious mononucleosis in active patients: definitive answers to common questions
1John Hopkins University School of Medicine, Baltimore, MD, USA. pauwaert@jhmi.edu.
Abstract:
Infectious mononucleosis may account for considerable illness, especially among adolescents and young adults. Although the disorder was well described more than 70 years ago as involving fever, sore throat, and lymphadenopathy, questions often arise about diagnosis and management. Because primary infection with the Epstein-Barr virus (EBV) can lead to diverse disease manifestation and complications, physicians must be well-versed in the disorder's epidemiology and pathophysiology. New information assesses the reliability of heterophil antibody testing and the role of EBV-specific antibody testing, and addresses issues of management, including corticosteroids, antiviral drugs, and restriction from athletic participation. Most athletes can return to sports after a minimum of 4 weeks, provided the spleen is not palpable.
Insights
Infectious mononucleosis, caused by Epstein-Barr virus (EBV), presents diagnostic and management challenges. Most athletes with mononucleosis can return to sports after four weeks if their spleen is not enlarged.
Area of Science:
- Infectious Diseases
- Virology
- Epidemiology
Background:
- Infectious mononucleosis causes significant illness, particularly in adolescents and young adults.
- Characterized by fever, sore throat, and lymphadenopathy, its diagnosis and management can be complex.
- Epstein-Barr virus (EBV) primary infection can manifest in diverse ways with potential complications.
Purpose of the Study:
- To review current information on infectious mononucleosis diagnosis and management.
- To assess the reliability of heterophil antibody testing and EBV-specific antibody testing.
- To provide guidance on managing infectious mononucleosis, including athletic participation.
Main Methods:
- Literature review of recent studies and clinical information.
- Evaluation of diagnostic testing reliability for Epstein-Barr virus.
- Analysis of management strategies, including pharmacological and non-pharmacological approaches.
Main Results:
- Heterophil antibody testing reliability is reassessed.
- The role of EBV-specific antibody testing in diagnosis is clarified.
- Guidelines for managing infectious mononucleosis and return-to-play protocols are discussed.
Conclusions:
- Physicians need to understand EBV epidemiology and pathophysiology for effective management.
- Accurate diagnosis relies on appropriate antibody testing.
- Athletes can typically resume sports after 4 weeks if spleen is not palpable.
More Related Videos
09:43An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
07:38Isolation of Tonsillar Mononuclear Cells to Study Ex Vivo Innate Immune Responses in a Human Mucosal Lymphoid Tissue
Published on: June 14, 2020
Related Concept Videos
Stages of Infection
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Myocarditis III: Medical Management
Cytomegalovirus Disease
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis IV: Nursing Management